AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclapack-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Koye Pharmaceuticals Pvt ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gliclapack-M Tablet SR

Diabetia-Comb SR tablets are anti-diabetic medications combining two drugs for adult type 2 diabetes management. They help regulate blood glucose. Take Diabetia-Comb SR with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continue taking this medication as prescribed, even if feeling well or achieving good blood sugar control; abrupt cessation can elevate blood sugar, risking kidney complications, vision loss, nerve damage, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar—symptoms include sweating, dizziness, headache, and tremors; carry a fast-acting glucose source), constipation, and vomiting. Alcohol increases hypoglycemia risk and should be avoided. Other possible side effects: altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your physician of any heart condition history before starting this medication. Pregnant or breastfeeding individuals should consult their doctor. Regular blood glucose monitoring and potential blood tests (to check blood cell counts and liver function) may be necessary.

Uses of Gliclapack-M Tablet SR

Adult-onset diabetes

Major Benefits of Gliclapack-M Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gliclapack-M Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Gliclapack-M Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclapack-M Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Gliclapack-M Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Gliclapack-M Tablet SR works:

Gliclazide and metformin are combined in the extended-release Gliclapack-M tablet to manage blood sugar.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliclapack-M Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Gliclapack-M tablets present a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Gliclapack-M tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, with possible adverse effects on the nursing child.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Gliclapack-M SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Gliclapack-M SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Gliclapack-M Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver dysfunction, initiate Gliclapack-M Tablet SR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Gliclapack-M Tablet SR :

Should you forget a Gliclapack-M Tablet SR dose, take it immediately if you remember. However, near the time for your next dose, omit the missed one and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Gliclapack-M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclapack-M Tablet SR

Gliclapack-M SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliclapack-M Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclapack-M Tablet SR can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Gliclapack-M Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). While rare, this side effect is more likely in individuals with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms may include muscle aches or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gliclapack-M Tablet SR and seek immediate medical attention.
Prolonged Gliclapack-M Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclapack-M Tablet SR is contraindicated in patients allergic to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol while taking Gliclapack-M Tablet SR is unsafe. This combination may dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclapack-M SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Gliclapack-M Tablet SR commonly causes side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use can result in vitamin B12 deficiency.
Gliclapack-M Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclapack-M Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is preventable by avoiding use in individuals with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experiencing these symptoms, discontinue Gliclapack-M Tablet SR and seek immediate medical attention.
Prolonged Gliclapack-M Tablet SR use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclapack-M Tablet SR is contraindicated in patients allergic to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Gliclapack-M SR tablets and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclapack-M Tablet SR
251
MRP 306
17% off